Latest Cancer News

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (02-26-2015)
The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment... Continue Reading

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma (02-25-2015)
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple... Continue Reading

FDA Approves New Indication for Ibrutinib in Waldenström’s Macroglobulinemia (02-24-2015)
The US Food and Drug Administration (FDA) today expanded the approved use of Imbruvica® (ibrutinib) for patients with Waldenström’s macroglobulinemia, a rare type of B-cell lymphoma. Imbruvica® is... Continue Reading

More Cancer News

Locations

 
Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
 
 
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
 
 
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
 
 
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611